山东医药
山東醫藥
산동의약
Shandong Medical Journal
2015年
35期
12-15
,共4页
骨髓间充质干细胞%外泌体%乳腺肿瘤%乳腺癌%PI3K/Akt信号通路
骨髓間充質榦細胞%外泌體%乳腺腫瘤%乳腺癌%PI3K/Akt信號通路
골수간충질간세포%외비체%유선종류%유선암%PI3K/Akt신호통로
bone marrow mesenchymal stem cells%exosomes%breast neoplasms%breast carcinoma%PI3K/Akt signa-ling pathway
目的:观察骨髓间充质干细胞(BMSCs)来源的外泌体(exosome)对小鼠乳腺癌细胞4T1增殖、侵袭的影响,并探讨其可能机制。方法将小鼠乳腺癌细胞4T1随机分为3组,4T1+vehicle组仅加入400μL无血清培养基,4T1+exosome组加入400μL由无血清培养基配置的exosome,4T1+exosome+磷脂酰肌醇3激酶( PI3K)/Akt信号通路阻断剂( Y294002)组加入400μL终浓度为5μmol/mL Y294002及400μg/mL exosome的培养基。分别采用MTT法、细胞划痕实验、Western blotting法检测各组细胞增殖、迁移和侵袭能力以及PI3K/Akt信号通路相关蛋白。结果4T1+exosome组、4T1+vehicle组、4T1+exosome+Y294002组细胞增殖抑制率分别为0.713%±0.050%、0.401%±0.030%、0.459%±0.800%,4T1+exosome组分别与4T1+vehicle组、4T1+exosome+Y294002组比较,P均<0.05。4T1+exosome组、4T1+vehicle组、4T1+exosome+Y294002组细胞迁移距离分别为(388.0±36.1)、(295.0±34.2)、(275.0±63.5)μm,4T1+exosome组分别与4T1+vehicle组、4T1+exosome+Y294002组比较,P均<0.05。4T1+exosome组p-AKT、β-catenin OD值分别为0.30±0.11、0.30±0.08,4T1+vehicle组分别为1.10±0.41、0.70±0.08,4T1+exosome+Y294002组分别为0.40±0.13、0.30±0.07,4T1+exosome组分别与4T1+vehicle组、4T1+exosome+Y294002组比较,P均<0.05。结论 BMSCs来源的exosome能够增加小鼠乳腺癌细胞4T1的增殖、迁移及侵袭能力,其机制可能与上调PI3K/Akt信号通路有关。
目的:觀察骨髓間充質榦細胞(BMSCs)來源的外泌體(exosome)對小鼠乳腺癌細胞4T1增殖、侵襲的影響,併探討其可能機製。方法將小鼠乳腺癌細胞4T1隨機分為3組,4T1+vehicle組僅加入400μL無血清培養基,4T1+exosome組加入400μL由無血清培養基配置的exosome,4T1+exosome+燐脂酰肌醇3激酶( PI3K)/Akt信號通路阻斷劑( Y294002)組加入400μL終濃度為5μmol/mL Y294002及400μg/mL exosome的培養基。分彆採用MTT法、細胞劃痕實驗、Western blotting法檢測各組細胞增殖、遷移和侵襲能力以及PI3K/Akt信號通路相關蛋白。結果4T1+exosome組、4T1+vehicle組、4T1+exosome+Y294002組細胞增殖抑製率分彆為0.713%±0.050%、0.401%±0.030%、0.459%±0.800%,4T1+exosome組分彆與4T1+vehicle組、4T1+exosome+Y294002組比較,P均<0.05。4T1+exosome組、4T1+vehicle組、4T1+exosome+Y294002組細胞遷移距離分彆為(388.0±36.1)、(295.0±34.2)、(275.0±63.5)μm,4T1+exosome組分彆與4T1+vehicle組、4T1+exosome+Y294002組比較,P均<0.05。4T1+exosome組p-AKT、β-catenin OD值分彆為0.30±0.11、0.30±0.08,4T1+vehicle組分彆為1.10±0.41、0.70±0.08,4T1+exosome+Y294002組分彆為0.40±0.13、0.30±0.07,4T1+exosome組分彆與4T1+vehicle組、4T1+exosome+Y294002組比較,P均<0.05。結論 BMSCs來源的exosome能夠增加小鼠乳腺癌細胞4T1的增殖、遷移及侵襲能力,其機製可能與上調PI3K/Akt信號通路有關。
목적:관찰골수간충질간세포(BMSCs)래원적외비체(exosome)대소서유선암세포4T1증식、침습적영향,병탐토기가능궤제。방법장소서유선암세포4T1수궤분위3조,4T1+vehicle조부가입400μL무혈청배양기,4T1+exosome조가입400μL유무혈청배양기배치적exosome,4T1+exosome+린지선기순3격매( PI3K)/Akt신호통로조단제( Y294002)조가입400μL종농도위5μmol/mL Y294002급400μg/mL exosome적배양기。분별채용MTT법、세포화흔실험、Western blotting법검측각조세포증식、천이화침습능력이급PI3K/Akt신호통로상관단백。결과4T1+exosome조、4T1+vehicle조、4T1+exosome+Y294002조세포증식억제솔분별위0.713%±0.050%、0.401%±0.030%、0.459%±0.800%,4T1+exosome조분별여4T1+vehicle조、4T1+exosome+Y294002조비교,P균<0.05。4T1+exosome조、4T1+vehicle조、4T1+exosome+Y294002조세포천이거리분별위(388.0±36.1)、(295.0±34.2)、(275.0±63.5)μm,4T1+exosome조분별여4T1+vehicle조、4T1+exosome+Y294002조비교,P균<0.05。4T1+exosome조p-AKT、β-catenin OD치분별위0.30±0.11、0.30±0.08,4T1+vehicle조분별위1.10±0.41、0.70±0.08,4T1+exosome+Y294002조분별위0.40±0.13、0.30±0.07,4T1+exosome조분별여4T1+vehicle조、4T1+exosome+Y294002조비교,P균<0.05。결론 BMSCs래원적exosome능구증가소서유선암세포4T1적증식、천이급침습능력,기궤제가능여상조PI3K/Akt신호통로유관。
Objective To observe the influence of bone marrow mesenchymal stem cells ( BMSCs)-derived exosome on the proliferation and invasion of mouse breast cancer cells 4T1 and to investigate the mechanism.Methods The mouse breast cancer cells 4T1 were randomly divided into three groups:4T1+vehicle group, 4T1+exosome group and 4T1+exosome+Y294002 (an inhibitor of PI3K/Akt signaling pathway) group.4T1+vehicle group was added with 400μL se-rum-free medium, 4T1+exosome group was added with 400 μL serum-free medium containing 400 μg/mL exosome and 4T1+exosome+Y294002 group was added with 400 μL serum-free medium containing 400 μg/mL exosome and 5 μg/mL Y294002.We used the MTT, cell scratch test and Western blotting to examine the effect of BMSCs-derived exosome on the proliferation, migration and invasion abilities as well as the PI3K/Akt signaling pathway of 4T1 cells.Results The in-hibition rates of cell proliferation of 4T1+vehicle group, 4T1+exosome group and 4T1+exosome+Y294002 group were 0.713%±0.05%, 0.401%±0.03%and 0.459%±0.80%, respectively.Significant difference was found between 4T1+exosome group and 4T1+vehicle group, 4T1+exosome+Y294002 group (all P<0.05).The cell migration distance of 4T1+vehicle group, 4T1+exosome group and 4T1+exosome+Y294002 group was (388.0 ±36.1), (295.0 ± 34.2) and (275.0 ±63.5) μm, respectively.Significant difference was found between 4T1+exosome group and 4T1+vehicle group, 4T1+exosome+Y294002 group (all P<0.05).The OD values of p-AKT and β-catenin of 4T1+exo-some group were 0.3 ±0.11 and 0.3 ±0.08, they were 1.1 ±0.41 and 0.7 ±0.08 in 4T1+vehicle group, 0.4 ±0.13 and 0.3 ±0.07 in the 4T1+exosome+Y294002 group.Significant difference was found between 4T1+exosome group and 4T1+vehicle group, 4T1+exosome+Y294002 group (all P<0.05).Conclusion BMSCs-derived exosome can promote the proliferation, migration and invasion abilities of mouse breast cancer cells 4T1, which may be related to the up-regulation of PI3K/Akt signaling pathway.